{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:47:23Z","timestamp":1788976043598,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Carriers of pathogenic DNA variants (G+) causing hypertrophic cardiomyopathy (HCM) can be identified by genetic testing. Several abnormalities have been brought forth as pre-clinical expressions of HCM, some of which can be identified by cardiovascular magnetic resonance (CMR). In this study, we assessed morphological differences between G+\/left ventricular hypertrophy-negative (LVH-) subjects and healthy controls and examined whether CMR-derived variables are useful for the prediction of sarcomere gene variants.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We studied 57 G+ subjects with a maximal wall thickness (MWT) &amp;lt; 13 mm, and compared them to 40 healthy controls matched for age and sex on a group level. Subjects underwent CMR including morphological, volumetric and function assessment. Logistic regression analysis was performed for the determination of predictive CMR characteristics, by which a scoring system for G+ status was constructed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> G+\/LVH- subjects were subject to alterations in the myocardial architecture, resulting in a thinner posterior wall thickness (PWT), higher interventricular septal wall\/PWT ratio and MWT\/PWT ratio. Prominent hook-shaped configurations of the anterobasal segment were only observed in this group. A model consisting of the anterobasal hook, multiple myocardial crypts, right ventricular\/left ventricular ratio, MWT\/PWT ratio, and MWT\/left ventricular mass ratio predicted G+ status with an area under the curve of 0.92 [0.87\u20130.97]. A score of \u22653 was present only in G+ subjects, identifying 56% of the G+\/LVH- population.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> A score system incorporating CMR-derived variables correctly identified 56% of G+ subjects. Our results provide further insights into the wide phenotypic spectrum of G+\/LVH- subjects and demonstrate the utility of several novel morphological features. If genetic testing for some reason cannot be performed, CMR and our purposed score system can be used to detect possible G+ carriers and to aid planning of the control intervals.<\/jats:p>","DOI":"10.3389\/fcvm.2021.727405","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:30:27Z","timestamp":1631853027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy"],"prefix":"10.3389","volume":"8","author":[{"given":"Nikki","family":"van der Velde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Huurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Carlijne","family":"Hassing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo P. J.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M. A.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend F. L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12265-009-9124-7","article-title":"Hypertrophic cardiomyopathy: preclinical and early phenotype","volume":"2","author":"Ho","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e001896","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Cir Genom Precis Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ehjci\/jes005","article-title":"Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers","volume":"13","author":"Brouwer","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcmg.2008.08.003","article-title":"Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch Myosin-Binding Protein C Founder Mutations","volume":"2","author":"Michels","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40477-018-0302-9","article-title":"Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes","volume":"21","author":"van Velzen","year":"2018","journal-title":"J Ultrasound"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1532-429X-14-17","article-title":"The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance","volume":"14","author":"Noureldin","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"B11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.amjcard.2018.08.040","article-title":"Effect of gender and genetic mutations on outcomes in patients with hypertrophic cardiomyopathy","volume":"122","author":"van Velzen","year":"2018","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"B17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron Martin","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2007.06.026","article-title":"Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance","volume":"50","author":"Johansson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12968-016-0250-5","article-title":"Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy","volume":"18","author":"Tarkiainen","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"B20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1573403X09666131202125424","article-title":"Basal septal hypertrophy","volume":"9","author":"Kelshiker","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"0310121","DOI":"10.1115\/1.4035585","article-title":"The effect of trabeculae carneae on left ventricular diastolic compliance: improvement in compliance with trabecular cutting","volume":"139","author":"Halaney","year":"2017","journal-title":"J Biomech Eng"},{"key":"B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"B23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e003259","DOI":"10.1161\/CIRCGEN.120.003259","article-title":"Prediction of genotype positivity in patients with hypertrophic cardiomyopathy using machine learning","volume":"14","author":"Liang","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1007\/s00330-020-07454-9","article-title":"Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images","volume":"31","author":"Zhou","year":"2021","journal-title":"Eur Radiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.727405\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:30:29Z","timestamp":1631853029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.727405\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2021.727405"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.727405","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"article-number":"727405"}}